Influence of health resort treatment combined with grape polyphenol concentrate on lipid profile and systemic inflammation markers in patients with asthma during the post-COVID period

   Aim. To assess the effect of health resort treatment combined with grape polyphenols on lipid metabolism and systemic inflammation markers in patients with asthma after COVID-19.

   Materials and methods. Patients with asthma and a history of COVID-19, undergoing health resort treatment at the I. M. Sechenov Research Institute of Health Resort Studies and Physiotherapy (Yalta), were divided into two groups. Group 1 included 48 patients who, in addition to standard health resort therapy, received a grape polyphenol concentrate. Group 2 comprised 45 patients treated exclusively with standard health resort therapy. Before and after treatment, the following assessments were performed: anthropometry (height, weight, body mass index [BMI]), pulse oximetry (SpO₂), spirometry with measurement of forced vital capacity (FVC) and forced expiratory volume in 1 second (FEV1), a 6-minute walk test, and blood analyses of C-reactive protein (CRP), total cholesterol, high-density lipoprotein (HDL), low-density lipoprotein (LDL), and triglycerides.

   Results. In asthma patients with post-COVID who received grape polyphenol concentrate during health resort treatment, significant changes were observed in BMI, lipid profile, and CRP levels. In Group 1, the mean BMI decreased from 29.4 kg/m² at admission to 29.0 kg/m² at discharge (p = 0.04). HDL rose from 1.4 to 1.9 mmol/L (p = 0.01). LDL dropped from 3.5 to
3.0 mmol/L (p = 0.03), triglycerides from 1.1 to 0.9 mmol/L (p = 0.04), and CRP from 3.8 to 2.9 mg/L (p = 0.01). No significant changes in lipid profile were observed in Group 2.

   Conclusion. Health resort treatment supplemented by grape polyphenol preparations helps correct lipid imbalance and reduce systemic inflammation in patients with asthma who have recovered from COVID-19.

1. Salukhov V.V., Kharitonov M.A., Zaitsev A.A., Ramazanova K.A., Assiamov K.V. [The modern significant of the bronchial asthma]. Bulletin of the Russian Military Medical Academy 2020; 2(70):227–234 (in Russian).

2. Leontieva N.M., Demko I.V., Sobko E.A., Ishchenko O.P. [Level of asthma symptom control and adherence to treatment in young patients]. Russian Medical Inquiry 2020; 4(4):180–185 (in Russian). doi: 10.32364/2587-6821-2020-4-4-180-185

3. Shchurok I.N. [Main fenotypes and biomarkers of asthma]. Immunopatologiya, allergologiya, infektologiya = Immunopathology, allergology, infectology 2020; 2:50–57 (in Russian). doi: 10.14427/jipai.2020.2.50

4. Nesterenko Z.V., Lagno O.V., Pankov E.A. [Search for new therapeutic targets in asthma. Review]. Pediatr = Pediatrician (St. Petersburg) 2022; 13(5):71–80 (in Russian). doi: 10.17816/PED13571-80

5. Pozdnyakova O.Yu., Grigoryan V.A., Gyatova O.V., Zinovieva L.M., Bagdasarova N.S. [Comorbidity in patients with uncontrolled bronchial asthma]. Cardiovascular therapy and prevention 2019; 18(S1):123–124 (in Russian).

6. Kushnikova I.P. [Prevention of comorbidity in patients with bronchial asthma. In: Healthy lifestyle and health protection : Collection of scientific articles of the II All-Russian Scientific and practical conference with international participation]. Surgut: Surgutskiy gosudarstvennyy pedagogicheskiy universitet; 2018: 235–238 (in Russian).

7. Malykhin F.T., Borlakova L.T., Kozlovskaya Ya.V., Marilova E.S. [The problem of comorbidity in chronic obstructive pulmonary disease and bronchial asthma. In: Focus on primary health care: modern clinical recommendations for the prevention and treatment of diseases in outpatient practice : X Anniversary Conference of general practitioners (family doctors) South of Russia]. Rostov-na-Donu: Rostovskiy gosudarstvennyy meditsinskiy universitet; 2015: 171–173 (in Russian).

8. Shchepikhin E.I., Shmelev E.I., Zaitseva A.S. [Respiratory diseases and obesity: special phenotype or independent events : review]. Terapevticheskii arkhiv 2022; 94(3):442–447 (in Russian). doi: 10.26442/00403660.2022.03.201412

9. Anikin D.A., Solovyova I.A., Demko I.V., Sobko E.A., Gordeeva N.V., Kraposhina A.Yu. [Analysis of cardiovascular and cardiometabolic risks associated with bronchial asthma and obesity]. Prakticheskaya meditsina = Practical medicine 2023; 21(4):30–36 (in Russian). doi: 10.32000/2072-1757-2023-4-30-36

10. Khlynova O.V., Bykova G.A., Tuev A.V. [Cardiovascular risks in the phenotype of «bronchial asthma with obesity» associated with non-alcoholic fatty liver disease]. Russian Cardiology Bulletin 2020; 15(S):81 (in Russian).

11. Liu H., Fu Y., Wang K. Asthma and risk of coronary heart disease: a meta-analysis of cohort studies. Ann. Allergy Asthma Immunol. 2017; 118(6):689–695. doi: 10.1016/j.anai.2017.03.012

12. Chiun Yu. H., Heather K.L., Beatrice L.W., Jaspreet B., Quratulain H., Bruce D.M. Comorbid obesity and depressive symptoms in childhood asthma: a harmful synergy. J. Allergy Clin. Immunol. Pract. 2020; 8(8):2689–2697. doi: 10.1016/j.jaip.2020.03.036

13. Baffi C.W., Winnica D.E., Holguin F. Asthma and obesity: mechanisms and clinical implications. Asthma Res. Pract. 2015; 1:1. doi: 10.1186/s40733-015-0001-7

14. Kamilova U.K., Masharipova D.R., Nuritdinov N.A., Utemuradov B.B., Tagaeva D.R., Petrova E.B., Pleshko A.A., Grigorenko E.A., Mitkovskaya N.P. [Assessment of the prevalence of cardiovascular events and factors that increase cardiovascular risk in patients with COVID-19]. Cardiology in Belarus 2023; 15(4):446–459 (in Russian). doi: 10.34883/PI.2023.15.4.002

15. Huang C., Wang Y., Li X. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395(10223):497–506. doi: 10.1016/S0140-6736(20)30183-5

16. Batishcheva G.A., Goncharova E.S., Ketova E.S. [Impact of the new coronavirus infection caused by SARS CoV-2 on the state of carbohydrate and lipid metabolism]. Nauchno-meditsinskiy vestnik Tsentral'nogo Chernozem'ya = Medical Scientific Bulletin of Central Chernozemye 2022; 89:4–8 (in Russian).

17. Kulikova N.G., Vinzhegina V.A., Chkheidze T.B., Kolodeznikova A.A., Tkachenko A.S. [Drug-free therapy of lipid metabolism in patients with cardiovascular pathology, after COVID-19, in course of aftertreatment (rehabilitation) in sanatorium conditions]. Bulletin of Rehabilitation Medicine 2022; 21(3):36–44 (in Russian). doi: 10.38025/2078-1962-2022-21-3-36-44

18. Kradinova E.A., Moshkova E.D., Alexandrov A.A., Lazareva E.G., Kulik E.I. [Effects of sanatorium treatment in patients with metabolic syndrome]. Vestnik Fizioterapii i Kurortologii 2020; 26(1):77 (in Russian).

19. Lobanov A.A., Grishechkina I.A., Andronov S.V., Fesyun A.D., Rachin A.P., Popov A.I. [Health and spa treatment in bronchial asthma: the efficiency of the method and the techniques]. Vestnik novykh meditsinskikh tekhnologiy 2021; 28(4):83–91 (in Russian). doi: 10.24412/1609-2163-2021-4-83-91

20. Shramko Yu.I., Fomochkina I.I., Kubyshkin A.V., Chernousova I.V., Ogai Yu.A., Petrenko V.I., Kropotka A.A., Gerashchenko E.F., Bykova N.L., Akayeva A.Z., Toncheva K.S., Ivashchenko N.A. [Study of metabolic syndrome correction by grape polyphenols]. Vinogradarstvo i vinodeliye 2020; 49:264–266 (in Russian).

21. Kubyshkin A.V., Shramko Yu.I., Zyablitskaya E.Yu., Petrenko V.I., Ivashchenko N.A., Tarim K.O., Chernousova I.V., Ogai Yu.A. [Use of natural products for correction of abdominal obesity in experimental metabolic syndrome]. Medical Bulletin of the North Caucasus 2020; 15(4):563–566 (in Russian). doi: 10.14300/mnnc.2020.15133

22. Shramko Yu.I., Kubyshkin A.V., Fomochkina I.I., Aliev L.L., Chegodar D.V., Ogai Yu.A., Chernousova I.V., Litvinova S.V., Tarim K.O. [Characteristics of active oxygen forms and antioxidants at experimental metabolic syndrome and its remodeling by grape polyphenols]. Ul′yanovskiy mediko-biologicheskiy zhurnal 2019; 4:103–113 (in Russian). doi: 10.34014/2227-1848-2019-4-103-113

23. Bitueva D.V., Drobik O.S., Goryachkina L.A. [Goals of bronchial asthma treatment and modern approaches to their achievement]. Effektivnaya farmakoterapiya 2012; 6:26–28 (in Russian).

24. Yatskov I.A., Shaduro D.V., Bubley K.V., Solovyova E.A. [The use of products based on grape polyphenols in the complex rehabilitation of patients who have suffered a new coronavirus infection in order to correct low-intensity inflammation. In: Collection of projects of the competition «All-Russian Scientific school «Young Medicine»]. Moscow: Mezhdunarodnyy fond razvitiya biomeditsinskikh tekhnologiy im. V.P. Filatova; 2023: 865–874 (in Russian). ISBN 978-5-6047317-6-5.

25. Bezrukov S.G., Bezrukov G.S., Tarim K.O., Ivashchenko N.A. [The effectiveness of the use of polyphenolic grape processing products in the treatment of experimental metabolic syndrome]. Tavricheskiy mediko-biologicheskiy vestnik 2021; 24(3):6–11 (in Russian). doi: 10.37279/2070-8092-2021-24-3-6-11

26. Kubyshkin A.V., Fomochkina I.I., Shramko Yu.I., Aliev L.L., Ogai Yu.A., Chernousova I.V., Zaitsev G.P., Alekhnovich A.V., Chegodar D.V., Petrenko V.I. [Pathogenetic correction of oxidative stress with natural concentrates of polyphenols]. Gospital′naya meditsina: nauka i praktika = Hospital Medicine: Science and Practice 2019; 1(2):54–61 (in Russian).

27. Chernousova I.V., Zaitsev G.P., Tarim K.O., Shramko Yu.I., Fomochkina I.I., Zhilyakova T.A., Grishin Yu.V. [Grape vine polyphenols: qualitative, quantitative composition, effectiveness of in vivo use in experimental metabolic syndrome. In: Science, nutrition and health: Collection of scientific papers]. Minsk: RUP «Izdatel'skiy dom «Belaruskaya navuka»; 2023: 442–449 (in Russian).

28. Beloglazov V.A., Yatskov I.A., Moik A.A., Moik A.V. [Prospects for the use of polyphenols in patients with bronchial asthma on the background of obesity]. Obesity and metabolism 2024; 21(4):357–364 (in Russian). doi: 10.14341/omet13092

29. Chávez-Carbajal A., Nirmalkar K., Pérez-Lizaur A., Hernández-Quiroz F., Ramírez-Del-Alto S., García-Mena J., Hernández-Guerrero C. Gut microbiota and predicted metabolic pathways in a sample of Mexican women affected by obesity and obesity plus metabolic syndrome. Int. J. Mol. Sci. 2019; 20(2):438. doi: 10.3390/ijms20020438

30. Mulders R.J., de Git K.-C.G., Schéle E, Dickson S.L., Sanz Y., Adan R.A.H. Microbiota in obesity: interactions with enteroendocrine, immune and central nervous systems. Obes. Rev. 2018; 19(4):435–451. doi: 10.1111/obr.12661